Marinus Pharma Q3 EPS $(0.61) Vs $1.89 Last Year, Sales $7.34M Beat $6.33M Estimate
Portfolio Pulse from Benzinga Newsdesk
Marinus Pharmaceuticals reported Q3 earnings per share (EPS) of $(0.61), compared to $1.89 last year. However, the company's sales of $7.34M beat the estimate of $6.33M.
November 07, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Marinus Pharmaceuticals reported a decrease in Q3 EPS but beat sales estimates. This mixed result could lead to uncertain market reactions.
Marinus Pharmaceuticals' Q3 earnings report shows a decrease in EPS, which could negatively impact the stock. However, the company beat sales estimates, which is a positive sign and could offset the negative impact of the lower EPS. The net effect on the stock price is uncertain.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100